• 6767 Bertner Ave, Mitchell Basic Science Research Building

    77030 Houston

    United States

  • 4472 Citations
  • 37 h-Index
19962019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 8 Similar Profiles
gemcitabine Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Cholangiocarcinoma Medicine & Life Sciences
Survival Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Gallbladder Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

1 Citations

Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer

Bernard, V., Kim, D. U., San Lucas, F. A., Castillo Arias, J. A., Allenson, K., Mulu, F. C., Stephens, B. M., Huang, J., Semaan, A., Guerrero, P. A., Kamyabi, N., Zhao, J., Hurd, M. W., Koay, E. J., Taniguchi, C., Herman, J. M., Javle, M., Wolff, R. A., Katz, M. H., Varadhachary, G. R. & 2 othersMaitra, A. & Alvarez, H. A., Jan 1 2019, In : Gastroenterology. 156, 1, p. 108-118.e4

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Nucleic Acids
Exosomes
Circulating Neoplastic Cells
DNA

Preoperative drainage for perihilar cholangiocarcinoma

Odisio, B. C., Krampitz, G. W., Murthy, R., Mahvash, A., Javle, M. & Vauthey, J. N., Jan 1 2019, In : The Lancet Gastroenterology and Hepatology. 4, 1, p. 10-11 2 p.

Research output: Contribution to journalLetter

Klatskin Tumor
Drainage
4 Citations

Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic Cancer

Wang, Y-N., Lee, H-H., Chou, C-K., Yang, W-H., Wei, Y., Chen, C. T., Yao, J., Hsu, J. L., Zhu, C., Ying, H., Ye, Y., Wang, W. J., Lim, S-O., Xia, W., Ko, H. W., Liu, X., Liu, C-G., Wu, X., Wang, H., Li, D. & 9 othersPrakash, L. REKA., Katz, M. H., Kang, Y., Kim, M., Fleming, J. B., Fogelman, D., Javle, M., Maitra, A. & Hung, M-C., Apr 9 2018, In : Cancer Cell. 33, 4, p. 752-769.e8

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Epidermal Growth Factor Receptor
Biomarkers
Ligands
Serum

A phase 1, open-label, dose escalation study of intravenous paricalcitol in combination with gemcitabine in patients with advanced malignancies

Fountzilas, C., Javle, M., Tan, W., Ma, Y., Fetterly, G., Iyer, R. & Johnson, C., Oct 1 2018, In : Cancer. 124, 19, p. 3890-3899 10 p.

Research output: Contribution to journalArticle

gemcitabine
Cytidine Deaminase
Calcitriol
Neoplasms
Hypercalcemia
2 Citations
Neoplasms
Standard of Care
Mutation
Therapeutics
Adenoids